Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Could Theralase rise like ICCM today?

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Dec 20, 2022 11:35pm

306 Views

Post# 35183846

RE:RE:RE:RE:RE:RE:Could Theralase rise like ICCM today?

plantrader wrote: N0ta, I like your Tolle reference! I know exactly what you mean.

Maybe I'm having memory dyslexia right now lol but aren't the under treated #s still within the acceptable parameters?

from all the experts here, yes. You would think the FDA would agree. Just hoping it doesn't create an issue where they want ALL submitted data to be clinically exact to be considered for AA. In which case, we would need to wait some more. Maybe it's a good thing, given the significantly better results. After 10 years, what's another six months.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?